Contraception News and Research

Latest Contraception News and Research

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

BioSante Pharmaceuticals' LibiGel clinical update to be presented at 2010 ISSWSH annual meeting

BioSante Pharmaceuticals' LibiGel clinical update to be presented at 2010 ISSWSH annual meeting

Gilead Sciences’ “Quad” regimen for HIV exhibits antiretroviral activity comparable to Atripla

Gilead Sciences’ “Quad” regimen for HIV exhibits antiretroviral activity comparable to Atripla

FDA grants approval for Abbott's antiretroviral medication Norvir

FDA grants approval for Abbott's antiretroviral medication Norvir

Contraceptive sex education and 'empowerment' for ten-year-old children

Contraceptive sex education and 'empowerment' for ten-year-old children

Study indicates women receiving antiretroviral therapy are more likely to become pregnant

Study indicates women receiving antiretroviral therapy are more likely to become pregnant

NPR examines Obama administration's global family planning policies

NPR examines Obama administration's global family planning policies

Public policy implications in abstinence-only programs

Public policy implications in abstinence-only programs

Transdermal estrogen therapies: Effective alternatives to oral estrogen and compounded bioidentical hormones

Transdermal estrogen therapies: Effective alternatives to oral estrogen and compounded bioidentical hormones

Reproductive coercion and partner violence increase risk of unintended pregnancy

Reproductive coercion and partner violence increase risk of unintended pregnancy

Watson Pharmaceuticals provides detailed overview of its global operations at Investor Day meeting in NY

Watson Pharmaceuticals provides detailed overview of its global operations at Investor Day meeting in NY

UNAIDS chief calls for reduction in MTCT in Africa

UNAIDS chief calls for reduction in MTCT in Africa

Antares Pharma, Population Council report positive Phase 2 results for novel NES/E2 contraceptive gel

Antares Pharma, Population Council report positive Phase 2 results for novel NES/E2 contraceptive gel

Obama administration supports Cairo conference goals, Clinton says

Obama administration supports Cairo conference goals, Clinton says

Health and development groups applaud Clinton speech; call for action

Health and development groups applaud Clinton speech; call for action

Phase II clinical trial of Gilead Sciences' elvitegravir, GS 9350 and Truvada meets primary objective

Phase II clinical trial of Gilead Sciences' elvitegravir, GS 9350 and Truvada meets primary objective

Discovery of inhibitory hormone may yield new treatments for cancer and other diseases

Discovery of inhibitory hormone may yield new treatments for cancer and other diseases

SenoRx wins patent infringement case

SenoRx wins patent infringement case

Teens, contraception and unplanned pregnancy

Teens, contraception and unplanned pregnancy

Catholics for Choice's statement on restriction of abortion coverage

Catholics for Choice's statement on restriction of abortion coverage

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.